首页> 外文OA文献 >The effect of hemofilter, preoperative and intraoperative methylprednisolone on complications after open heart surgery
【2h】

The effect of hemofilter, preoperative and intraoperative methylprednisolone on complications after open heart surgery

机译:血液过滤,术前和术中甲基胚芽酮对开放性心脏手术后并发症的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Complications after open heart surgery may threaten patient’s survival rate. Theintraoperative methylprednisolone administration alone shows controversial resultson open heart surgery complications. Similarly, the intraoperative and preoperativemethylprednisolone administration as well as the use of hemofilter in open heart surgeryis still controversial. This study aimed to evaluate the effect of hemofilter, preoperativeand intraoperative methylprednisolone administration on complications following openheart surgery. This was a Prospective Randomized Open-Blinded Evaluation (PROBE)experimental study. Ninety-five patients who had open heart surgery in Dr. SardjitoGeneral Hospital, Yogyakarta, and Integrated Cardiac Care of Dr. Cipto MangunkusumoGeneral Hospital, Jakarta within the period of December 2011 to May 2012 wereinvolved in this study. The patients were divided into two groups i.e. group A, 48 patientsreceived methylprednisolone 15mg/kg intraoperatively, methylprednisolone 5mg/kgpreoperatively, and hemofilter, while group B, 47 patients received methylprednisolone15mg/kg intraoperatively alone. From the total 95 patients, we found 26 (27.4%)patients experienced complications i.e. 19 in group B (40.4%) and 7 in group A(14.6%). The differences of the complications were statistically significant (p<0.05;OR=3.97; 95%CI=1.476-10.71). Complications risk decreased by 63.9% in the groupA compared to the group B with the hazard ratio of 3.2. In conclusion, the application ofhemofilter, preoperative and intraoperative methylprednisolone might decrease the risk ofcomplications after open heart surgery.
机译:开放心脏手术后的并发症可能会威胁患者的生存率。单独的TheTRAoperative甲基丙酮管理局显示出争议的结果开放心脏手术并发症。同样地,术中和术前丙二甲基酮酮给药以及血液过滤器在开放心脏外科仍然存在争议。本研究旨在评估血液过滤器,术前术中甲基己酮酮对术后并发症的影响。这是一个预期随机开放式评估(探针)实验研究。在2011年12月至2012年5月,雅加达在2012年12月至2012年5月,雅加达博士在萨达特州医院,日惹和Cr.Cr.Calgungusumogalogy医院综合心脏护理中开放了心脏手术的九十五名患者。将患者分为两组I.e.S,48名患者甲基丙酮酮15mg / kg术中,甲基己酮5mg / kgPReoperatial,而血液过滤器,47名患者单独接受甲基喹啉甲基喹啉酮15mg / kg。从95例患者中,我们发现26例(27.4%)患者经历了并发症,即B组(40.4%)和A组(14.6%)。并发症的差异在统计学上显着(P <0.05;或= 3.97; 95%CI = 1.476-10.71)。与危害比率为3.2的B组相比,在G组相比,Groupa的并发症风险降低了63.9%。总之,半过滤器,术前和术中甲基丙酮醇的应用可能会降低开放性心脏手术后的符合障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号